Qure.ai Lung Nodule Management

Application

Lung nodule management with a patented, clinically validated malignancy risk score for detected nodules, built on qXR-LN and qCT.

Find alternatives to Qure.ai Lung Nodule Management

TypeApplication
RoleStandalone tool
AvailabilitySold
DeploymentSaaS
Intended forEnterprise
SecurityNot recorded
StatusActive
Sold withinPackaging not stated — the vendor’s page was checked and named no parent or plan
PricingEnterprise quote — official pricing ↗

What it does

Features 4

qure.ai

Sources

Pricing

Pricing page · 10 Nov 2026

No price is published; the vendor quotes on request. The legal page sets invoice terms only. Pricing page: "All invoices raised by Qure shall be payable by You within thirty (30) days from the date of the invoice."

Description

Official documentation · 10 Nov 2026

Product page: "patented and clinically validated Lung Nodule Malignancy (LNM) Risk Score for nodules detected to reduce false positives"

What it does

Official documentation · 10 Nov 2026

Product page: "patented and clinically validated Lung Nodule Malignancy (LNM) Risk Score for nodules detected to reduce false positives"

Sold within

Not found · 10 Nov 2026

No self-serve or standalone-rate evidence on the product page; sold through the vendor's sales channel.

Name

Official documentation · 10 Nov 2026

Name as published on the product page.

URL

Official documentation · 10 Nov 2026

Product page, read 2026-11-10.

Deployment

Official documentation · 10 Nov 2026

Product page: sold to hospitals and programmes as a hosted service; the vendor's own regulatory page states which products are cleared.

Interfaces

Official documentation · 10 Nov 2026

Product page: sold to hospitals and programmes as a hosted service; the vendor's own regulatory page states which products are cleared.

Also from Qure.ai

Open Qure.ai in the directory

Something wrong here? Send a correction — quote this product id: qure-lung-nodule-management.